fls.txt



item1.txt
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
[1] Prior year balances have been restated to reflect the retrospective application of the new revenue recognition accounting standard.
See notes to condensed consolidated financial statements.
The interim financial statements are unaudited, but reflect all adjustments which are, in the opinion of management, of a normal, recurring nature necessary to provide a fair statement of results for the interim periods presented.
The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending March 30, 2019 or any future period.
The Company uses a 52- to 53-week fiscal year ending on the Saturday nearest March 31.
The authoritative guidance provides a five-step process for recognizing revenue that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services.
Previously, revenue was recognized upon reported resale of the product by the distributors to their customers (sell-through) as reduced by actual allowances for distributor price adjustments.
Revenue recognition related to the Company's other revenue streams, such as direct customers, remains unchanged.
The authoritative guidance does not change the guidance for classifying and measuring investments in debt securities and loans.
Subsequent changes in fair value from such investments are recorded in the condensed consolidated statements of income.


item2.txt
The reader should not place undue reliance on these forward-looking statements.
•Advanced Products include our most recent product offerings and consist of the UltraScale+, UltraScale and 7-series product families.
•Core Products consist of all other product families.
Specifically, we are grouping the products manufactured at the 28 nanometer (nm), 20nm and 16nm nodes into a category named Advanced Products while all other products are grouped in a category named Core Products.


item3.txt
These securities are subject to interest rate risk and will decrease in value if market interest rates increase.


item4.txt



part2.txt
Contingencies" to our condensed consolidated financial statements, included in Item 1.
"Financial Statements" for information regarding patent litigation.
The following risk factors and other information included in this Quarterly Report on Form 10-Q should be carefully considered.
The risks and uncertainties described below are not the only risks to the Company.
Additional risks and uncertainties not presently known to the Company or that the Company’s management currently deems immaterial also may impair its business operations.
In addition, we also have wafers manufactured in South Korea by Samsung Electronics Co., Ltd.
We are dependent on these foundries to supply the substantial majority of our wafers.
We rely on TSMC, UMC and our other foundries to produce wafers with competitive performance attributes.


